| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.8 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |